Systemic and pulmonary effects of vasopressors and inotropes in the neonate.
This paper briefly reviews the systemic and pulmonary hemodynamic actions of the most frequently used vasopressor-inotropes and inotropes in the preterm and term neonate. It is important to note that very little is known about the medium- and long-term cardiovascular and neurodevelopmental benefits of the use of these medications in the neonate.
Seri
Istvan
I
Department of Pediatrics, Children's Hospital Los Angeles, LAC/USC Medical Center, Keck School of Medicine, University of Southern California, Los Angeles, Calif., USA. iseri@chla.usc.edu
D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology; D014662:Vasoconstrictor Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*
D014662:Vasoconstrictor Agents